|
|
| 5-Day | 27,602 |
| 10-Day | 48,898 |
| 30-Day | 32,210 |
| 5-Day | 27,602 |
| 10-Day | 48,898 |
| 30-Day | 32,210 |
| 5-Day | 550,186 |
| 10-Day | 459,414 |
| 30-Day | 374,203 |
| 5-Day | 550,186 |
| 10-Day | 459,414 |
| 30-Day | 374,203 |
Announcements
Dr Reddys Laboratories Q3 results on Jan 29, 2015
Dr Reddys Labs
Sentimeter
100% of moneycontrol users recommend buying Dr Reddys Labs.
What's your call on Dr Reddys Labs today?
Read 14 investor views
Top Trading Ideas
30 January 2015
buy Century Jan Fut |
Entry Price (Rs) 580.00 |
Exit Price (Rs) 584.00 |
Gain (Rs) 4.00 |
buy TataChemicals Jan Fut |
Entry Price (Rs) 462.00 |
Exit Price (Rs) 467.00 |
Gain (Rs) 5.00 |
sell BankIndia Jan Fut |
Entry Price (Rs) 275.00 |
Exit Price (Rs) 268.00 |
Gain (Rs) 7.00 |
sell BankBaroda Jan Fut |
Entry Price (Rs) 215.00 |
Exit Price (Rs) 207.00 |
Gain (Rs) 8.00 |
buy Grasim Jan Fut |
Entry Price (Rs) 3,915.00 |
Exit Price (Rs) 3,935.00 |
Gain (Rs) 20.00 |
buy NIFTY Jan Fut |
Entry Price (Rs) 8,881.00 |
Exit Price (Rs) 8,955.00 |
Gain (Rs) 74.00 |
| NSE SERIES | LAST PRICE | CHANGE(%) | OPEN | HIGH | LOW | FACE VALUE |
|---|---|---|---|---|---|---|
| N1 | 3,397.15 | 0.00% | 3,275.00 | 3,458.00 | 3,232.15 | 5 |
| Days | BSE | NSE |
| 30 | 3213.35 | 3214.61 |
| 50 | 3308.87 | 3310.31 |
| 150 | 3052.48 | 3053.27 |
| 200 | 2915.14 | 2915.98 |
Click here to view the Open, High, Low, Close, Volume and Spread data for Dr Reddys Labs
| Consolidated | (Dec '14) | (Sep '14) |
| Net Sales | 3,843.10 | 3,587.81 |
| Other Income | 105.95 | 26.56 |
| PBDIT | 828.62 | 646.52 |
| Net Profit | 574.53 | 574.10 |
| Total Share Capital | 85.10 |
| Net Worth | 9329.00 |
| Total Debt | 2664.50 |
| Net Block | 2748.30 |
| Investments | 2806.50 |
| Net Current Assets | 5862.60 |
| Total Assets | 11993.50 |
| Company Name | Last Price | % Change |
52 wk High |
52 wk Low |
Market Cap |
| Sun Pharma | 915.95 | -0.35 | 939.05 | 552.50 | 189,708.26 |
| Lupin | 1584.35 | 1.86 | 1589.40 | 882.80 | 71,189.88 |
| Cipla | 696.05 | 0.11 | 711.45 | 366.70 | 55,890.06 |
| Dr Reddys Labs | 3237.00 | -3.64 | 3662.00 | 2250.00 | 55,151.92 |
| Aurobindo Pharm | 1248.10 | 2.08 | 1251.85 | 476.75 | 36,419.05 |
| More » | |||||
| Dec' 14 | Sep' 14 | Jun' 14 | Mar' 14 | |
| Promoter | 25.49 | 25.49 | 25.49 | 25.52 |
| FII | 38.53 | 38.41 | 35.29 | 34.30 |
| DII | 5.66 | 5.38 | 5.44 | 6.29 |
| Others | 30.32 | 30.72 | 33.78 | 33.89 |
| Total | 100.00 | 100.00 | 100.00 | 100.00 |
| Scheme | No. of Shares |
| Franklin India Bluechip Fund (G) | 552,335 |
| ICICI Prudential Focused Bluechip Equity Fund (G) | 335,927 |
| Birla Sun Life Frontline Equity Fund (G) | 335,367 |
| Franklin India Prima Plus Fund (G) | 255,942 |
Nile Recommended on Oct 23rd 2014
Recommended price 186.00 | Peak from reco 371.40 100.16%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Dr Reddys Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 55,151.92 crore.The company has reported a consolidated sales of Rs 3,843.10 crore and a Net Profit of Rs 574.53 crore for the quarter ended Dec 2014.
The company management includes Satish Reddy - Chairman, G V Prasad - Co-Chairman & Manag. Director, Anupam Puri - Independent Director, Ashok S Ganguly - Independent Director, Bruce L A Carter - Independent Director, J P Moreau - Independent Director, Sridar Iyengar - Independent Director, Kalpana Morparia - Independent Director, Ravi Bhoothalingam - Independent Director, Omkar Goswami - Independent Director.
It is listed on the BSE with a BSE Code of 500124 and the NSE with an NSE Code of DRREDDY.
Its Registered office is at 8-2-337, Road No. 3,,Banjara Hills Hyderabad,Telangana - 500034.
Their Registrars are Bigshare Services Pvt. Ltd.
SET SMS ALERT
